MRI aspects of left ventricular non compaction (LVNC): About 3 cases from Sub-Saharan Africa and review of the literature

Touré, Abdoulaye; Gnaoulé, Debato Tina; Ahoury, Judicael; N’dja, Ange Patrick; Zouzou, Ange Eric; Dion, Anicet Le; Fatto, Nguessan Ebeyss; Gbazi, G.C.

doi:10.1016/j.radcr.2022.01.049

Cited by 1 publication

(1 citation statement)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…"The diagnosis is usually established by identifying the morphologic diagnostic criteria proposed by Jenni and al. on transthoracic echocardiography [13] and MRI which is the second modality, with an excellent spatial resolution, is the best method because it has not only a diagnostic but also a prognostic role" [14]. "LVNC can be diagnosed with ECG-triggered low-dose CCT (cardiac computed tomography) with a very good correlation of NC:C ratio in TTE and CCT" [15].…”

Section: Discussionmentioning

confidence: 99%

A Young Healthy Woman with Supraventricular Tachycardia Reveals an Underlying Left Ventricular Non-compaction Cardiomyopathy: A Rare Case Report

Tahir

Mulendelé²,

Foudail³

et al. 2023

View full text Add to dashboard Cite

LVNC (left ventricular non-compaction) is a rare congenital cardiomyopathy with a reported incidence of 0.05% in adults. It can occur in isolation or affect both ventricles. It’s characterized by prominent LV trabeculae and deep intertrabecular recesses which are filled with blood from the ventricular cavity without evidence of communication to the epicardial coronary artery system. Frequent premature supra ventricular tachycardia as unique finding in LVNC cardiomyopathy is rare manifestation of this disease. We report a case of a frequent persistent supraventricular tachycardia as first manifestation of a patient with LVNC cardiomyopathy in a young healthy woman who despite radio frequency ablation therapy of the supraventricular tachycardia remains symptomatic. The patient was later placed on medical therapy based on a non-cardio selective beta-blocker with a good clinical outcome without recurrent of supra-ventricular arrythmias.

show abstract

Section: Discussionmentioning

confidence: 99%